Amplitude Vascular Systems (AVS) announced results from the first 95 patients treated in the POWER PAD II United States ...
Amplitude Vascular Systems (AVS) today announced findings from the first 95 patients treated in its POWER PAD II U.S. pivotal ...
Boston-based medical device company AVS (Amplitude Vascular Systems) raised $20 million in Series B funding on Thursday to bring its arterial disease treatment closer to FDA clearance. The financing ...
Data from the POWER PAD II Study presented at VIVA will support FDA 510 (k) submission in 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback